Furthermore, serum miR-182 levels were significantly lower in oestrogen receptor (ER)- and progesterone receptor (PR)-positive breast cancer patients than those in ER- and PR-negative patients, demonstrating their clinical utility for breast cancer diagnosis [165]. Here, PGR is linked to breast carcinoma.